Alerts

Consumers are advised to stop using Hydroxycut products due to reports of serious adverse reactions, including liver toxicity, and to consult their doctor if they have any concerns.

Be aware that Hydroxycut products purchased via the internet may be sourced from the US and may contain ingredients which are not permitted in low-risk medicines in Australia

Weight loss drug Sibutramine (Reductil) under safety review for cardiovascular risks.

We are advising that there are supply issues with Physeptone (methadone) tablets due to quality control problems.

Approval has been granted for the Panvax H1N1 vaccine in children starting at 6 months, with Panvax H1N1 Junior for ages 6 months to 3 years.

In October 2009 an anaphylactic reaction to the Panvax H1N1 pandemic influenza vaccine was reported in Western Australia in a person known to have a pre-existing latex allergy.

Ginkgo biloba products with high quercetin and rutin levels have been identified. Quality standards are being reviewed.

Panvax H1N1 influenza vaccine has been approved for use in adults and children over 10 years old, with additional data needed for younger children.

The bolts used to secure the caster assemblies to the wheelchair frame can fail in use.

Advise to exercise caution when using Australian Hydroxycut products

Chuan Xiong Cha Tiao Wan pills have been recalled due to the presence of aristolochic acids, which can cause severe kidney damage and urinary tract cancer. Stop using them immediately and consult your doctor for advice.

Chuan Xiong Cha Tiao Wan pills (recall notice)

Updated web advisory.

Updated web advisory.

Updated web advisory.

Urgent web advisory.